MINNEAPOLIS, Aug. 8 /PRNewswire-FirstCall/ -- MedicalCV, Inc. (OTC:MDCV) (BULLETIN BOARD: MDCV) , http://www.medcvinc.com/, a cardiovascular surgery device manufacturer, announced today that its...
MedicalCV Establishes Scientific Advisory Board Comprised of Distinguished Cardiac Surgeons and Scientific Experts Dr. Patrick M. McCarthy, Chief of Cardiothoracic Surgery at Northwestern Memorial...
MedicalCV to Present at Medtech Insight's 'Investment in Innovation' Conference Company Scheduled to Present in San Francisco on Tuesday, June 14, 2005 MINNEAPOLIS, June 14...
MedicalCV Announces Addition of Industry Experts to ATRILAZE(TM) Research & Development Team Company Takes Proactive Steps to Enhance Strategic Growth MINNEAPOLIS, May 26 /PRNewswire-FirstCall/...
MedicalCV Announces Information to Be Available Through S&P Market Access Program MINNEAPOLIS, May 2 /PRNewswire-FirstCall/ -- MedicalCV, Inc. (OTC:MDCV) (BULLETIN BOARD: MDCV...
MedicalCV Announces Completion of a Series of U.S. Clinical Cases Using the ATRILAZE(TM) System for Cardiac Tissue Ablation Two Months After Surgery All Patients Show Freedom from Atrial...
MedicalCV Announces Sales of the Omnicarbon(R) Mechanical Heart Valve to Cease on April 30, 2005 Company Gaining Market Recognition of Its ATRILAZE(TM) Surgical Ablation System MINNEAPOLIS, April...
MedicalCV Announces Industry Recognition Excellence in Technology Award from Frost and Sullivan Company Receives Industry Recognition in the Field of Surgical Ablation Technologies MINNEAPOLIS...
MedicalCV, Inc. Signs and Closes $13.6 Million Private Financing and Converts $4.4 Million of Debt Into Equity MINNEAPOLIS, April 4 /PRNewswire-FirstCall/ -- MedicalCV, Inc. (OTC:MDCV) (BULLETIN...
MedicalCV Announces Retention of ROI Group Associates, Inc. as Its Investor Relations Firm MINNEAPOLIS, Jan. 31 /PRNewswire-FirstCall/ -- MedicalCV, Inc. (OTC Bulletin: MDCV...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales